Member Info for inanaco

I have no idea what you are talking about Ruck ....

by the way Confidence has nothing to do with it, we have been buyers of scancell well before the Grand Challenge bid and at a higher SP ... based on sound science, so apart from the difficulty in scaleup manufacture of Modi1 (overcome)
the only thing that has changed is estimated start dates ... even with £billion pound investments the trains are still late so it's always a consideration , but as Scancell is a High Technology investment and not a calendar printer, some shareholder should try and stay calm ..

I have left out Ichor as Scancell cannot technically sort out that issue as its Ichor problem now. As its already in trial and the new device appears to be ok in patients then whatever the FDA is looking for its not because the device has issues. Scancell have already stated the paperwork for them would be sorted by Dec 2018 as we have had no rns to state it has not, or another problem we can assume all is well.

Point being that if "PLC" where not involved, then Mrs Release would not stay up till gone midnight on the 22nd

Scancells bid includes US and UK business

Released when all markets are closed ... !!

what destroys business is uncertainty .. and your advocating another 30 years of it .. 50/50 in the country will just continue to fight it out ... """when one side has had 40 years to convince the other side and Failed"""" ... so not quite sure how Gary Lineker can win this one ...

https://twitter.com/KTHopkins?lang=en-gb

i suggest some should be careful what they wish for

Interesting JUly then Crumbs

however i suggest you read the EU own verdict

https://www.express.co.uk/news/politics/1064892/EU-news-Brexit-latest-brussels-European-Union

TF .. funding emails do not happen ...simple, even repeated questions on funding do not get replied to at AGM's .. apart from "funding will be required at some point. " which you find in RNS so his comments do not merit the attention you are giving them.

Not quite sure why you are reading anything into his posts ? what has he actually inferred ? funding not needed in January ?

Hate to state the obvious but we have approaching £10m in the bank ... with the next two or three years research funding if we win the Grant ...

all getting a bit tedious .... talking of posts of Doom etc ... this from Knowlesi the other day .. tactical post, spreading Doom followed by an uplift ... however the market seems to have moved against him ..

SCLPRE: Crumbs 15.5418 Dec '18
Agree I doubt anyone is selling now with a view to buy back cheaper - I actually think the sellers are just moving on and going elsewhere - I do think a lot of people have completely lost faith and hence sold up - the share price chart shows that story playing out over the last few years. Will turnaround on data, trials, deals, GC win etc - we just need some positive momentum. I won't be popular but I am almost writing off the next 12-18 months - mid 2020 and beyond will see a substantial re-rate and but substantial I mean into multiple pounds.

what you will notice in all these Doom posts ...

""The Missing elements of the science sitting behind scancell"""

so if Knowlesi is "writing off" the next 12 to 18 months why is he still here ???

Researcher 1 ........ Lindy is not CEO now and would only have an idea of what is likely to happen regarding funding until a board meeting after intimate talks on funding proposals had been presented, as such your statements are at best ridiculous and at worse tantamount to market manipulation. For sure Lindy would not even reply to you.

you explained that I did not know the difference between debt and a grant ....

Really ... ?

that is what is so petty ...

the debate was about how it interacts with the balance sheet. not how it was distributed

Roses you created a debate with yourself

and just repeated what i had written

have a good day, but these relentless petty posts are just not worth my time

what part of his post ? two paths ?

agreeing with somebody that lays out many options is interesting

i was trying to explain to c7 how it interacts with the balance sheet

i can hardly use an example of a grant to highlight a grant ...

you are trying to be clever for the wrong reasons

why do you need to repeat my posts ?

smart man .. however its application as to how the balance sheet see's it is the same

thank you for explaining the difference between a Debt and a Grant ...

who would have thought it ...

The Tax credits could represent about £4m which boosts the balance sheet as well

last year we received £744,000 tax credit on a £4m expenditure

i do not know the exact breakdown or the finer points of it ... as i am not a corporate accountant ... however they do exist ...

if a bank gives you an overdraft does that sit on the balance sheet ? NO

same would apply to the Grant ..

however you can no spend up to the overdraft limit ...

same with the grant

you can spend up to the £20m limit on modi3

that expenditure creates a paper trail that sits on the balance sheet and even creates a positive tax position "tax credits"

"" I asked because it is my understanding it doesnt appear on our balance sheet? """

what do you mean

C7 If any monies come into Scancell it has to appear in the Balance sheet ... its a Not for profit amount ie it can only be spent on research and development of the modi3 program ... the profit is actually the IP that's developed

Scancell has a balance sheet all based on research and development .. so really not sure what you mean

it all starts at the bottom ... the innate system
it then moves to the adaptive .... our CD8 killer cells helped by the Generals the CD4

the Top Predator in the immune system is a General (CD4) that has gone cytotoxic its the one predator that can shape and change the environment including itself to suit any condition
Why do you die when you lose CD4 from HIV ? all command and control is removed ...

the only company that has the IP on CD4 is Scancell .. we are the shark ...

how to make money
1/ has company sufficient cash ?
2/ has company the IP ... has it been proven by other scientists that the work has legs
Genentech, BioNtech, Karolinska, ISA pharma, Cancer research UK

does it have diversity
Immunobody .. SCIB1 in the clinic and SCIB2 in final testing

does it have a pipeline ..
pretty well all cancers

whats not to like ?